Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine

被引:336
作者
Poehling, KA
Talbot, TR
Griffin, MR
Craig, AS
Whitney, CG
Zell, E
Lexau, CA
Thomas, AR
Harrison, LH
Reingold, AL
Hadler, JL
Farley, MM
Anderson, BJ
Schaffner, W
机构
[1] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Sch Med, Ctr Educ & Res Therapeut, Nashville, TN 37232 USA
[5] Tennessee Dept Hlth, Nashville, TN USA
[6] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA USA
[7] Minnesota Dept Hlth, Minneapolis, MN USA
[8] Oregon Dept Human Serv, Off Dis Prevent & Epidemiol, Portland, OR USA
[9] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[10] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA
[11] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[12] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA
[13] Connecticut Dept Hlth, Infect Dis Sect, Hartford, CT USA
[14] Emory Univ, Sch Med, Atlanta, GA USA
[15] Atlanta Vet Affairs Med Ctr, Atlanta, GA USA
[16] New York State Dept Hlth, Emerging Infect Program, Albany, NY USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 295卷 / 14期
关键词
D O I
10.1001/jama.295.14.1668
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Streptococcus pneumoniae is a serious infection in young infants. A heptavalent pneumococcal conjugate vaccine (PCV7) was licensed in 2000 and recommended for all children aged 2 to 23 months. Objective To determine the rates of invasive pneumococcal disease (IPD) in young infants before and after PCV7 was incorporated into the childhood immunization schedule in June 2000. Design, Setting, and Participants A prospective, population-based study of infants aged 0 to 90 days who resided in areas in 8 US states with active laboratory surveillance for invasive S pneumoniae infections from July 1, 1997, to June 30, 2004. Main Outcome Measures Rates of laboratory-confirmed IPD before (July 1, 1997-June 30, 2000) and after (July 1, 2001-June 30, 2004) PCV7 introduction, excluding a transition year (July 1, 2000-June 30, 2001). Results There were 146 cases of IPD, 89 before and 57 after PCV7 introduction. Isolated bacteremia occurred in 94 cases (64%), pneumonia in 27 (18%), meningitis in 22 (15%), and septic arthritis and/or osteomyelitis in 3 (2%). Mean rates of IPD for infants aged 0 to 90 days decreased 40% from 11.8 (95% confidence interval [CI], 9.6-14.5) to 7.2 (95% CI, 5.6-9.4; P = .004) per 100 000 live births following PCV7 introduction. Among black infants, mean rates of IPD decreased significantly from 17.1 (95% CI, 11.9-24.6) to 5.3 (95% CI, 2.8-10.1; P = .001) per 100 000 live births, with a nonsignificant decrease from 9.6 (95% CI, 7.3-12.7) to 6.8 (95% CI, 4.9-9.4) per 100 000 live births for white infants. Rates of PCV7-serotype isolates decreased significantly from 7.3 (95% CI, 5.3-10.1) to 2.4 (95% CI, 1.6-3.8; P < .001) per 100 000 live births, while rates of non-PCV7 serotypes remained stable (P = .55). Conclusions Since PCV7 introduction, rates of IPD in young infants have decreased significantly, providing evidence that vaccinating children aged 2 to 23 months has led to changes in pneumococcal carriage in infants too young to receive PCV7. With a significant decrease in rates of IPD among black infants, the previous racial difference has been eliminated.
引用
收藏
页码:1668 / 1674
页数:7
相关论文
共 36 条
[1]  
Abramson JS, 2000, PEDIATRICS, V106, P362
[2]  
[Anonymous], 2000, MMWR Recomm Rep, V49, P1
[3]   Pediatric pneumococcal bone and joint infections [J].
Bradley, JS ;
Kaplan, SL ;
Tan, TQ ;
Barson, WJ ;
Arditi, M ;
Schutze, GE ;
Wald, ER ;
Givner, LB ;
Mason, EO .
PEDIATRICS, 1998, 102 (06) :1376-1382
[4]  
*CDCP, 2001, NAT IMM SURV
[5]  
Centers for Disease Control and Prevention, ACT BACT COR SURV RE
[6]  
*CT DEP PUBL HLTH, 1997, CONN LIV BIRTH DAT
[7]  
*CTR HLTH STAT OFF, 1997, CAL LIV BIRTH DAT
[8]   Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus [J].
Dagan, R ;
Givon-Lavi, N ;
Fraser, D ;
Lipsitch, M ;
Siber, GR ;
Kohberger, R .
JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (03) :367-376
[9]   Effectiveness of a nationwide infant immunization program against Haemophilus influenzae b [J].
Dagan, R ;
Fraser, D ;
Roitman, M ;
Slater, P ;
Anis, E ;
Ashkenazi, S ;
Kassis, I ;
Miron, D ;
Leventhal, A .
VACCINE, 1999, 17 (02) :134-141
[10]   Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections [J].
Flannery, B ;
Schrag, S ;
Bennett, NA ;
Lynfield, R ;
Harrison, LH ;
Reingold, A ;
Cieslak, PR ;
Hadler, J ;
Farley, MM ;
Facklam, RR ;
Zell, ER ;
Whitney, CG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (18) :2197-2203